Osiris Therapeutics Announces Scientific Manuscript Reporting...

Osiris Therapeutics Announces Scientific Manuscript Reporting...


Osiris Therapeutics, Inc. , announced today that a new peer-reviewed manuscript "Human cryopreserved viable amniotic membrane inhibits the growth of bacteria associated with chronic wounds" has been published in the Journal of Diabetic Foot Complications and available online . Chronic wounds are on the rise and represent an enormous financial burden to the patient and to the healthcare system.



from Biotech News